EFSA Provision of documents
Public consultation on rapporteur Member State assessment reports submitted for the EU peer review of active substances used in plant protection products

EFSA wishes to increase the level of stakeholder involvement in the EU peer review of active substances used in plant protection products. As part of this process, EFSA opens a 40-day public consultation period on the risk assessment provided by the rapporteur Member State. In accordance with relevant legislation, confidential information has been removed from the assessment reports upon justified request of the respective applicant(s). A guidance document regarding information eligible for removal is available.

When a rapporteur Member State assessment report becomes available, the public consultation will be started via this EFSA website. Comments are to be limited to the risk assessment presented in the assessment report, and submitted using the available template for electronic provision of comments.

To obtain an assessment report, please click on the active substance name. A duly completed online request form needs to be submitted in order to receive an email providing access to the respective documentation. Comments should be sent by email to EFSA (DAR_consultation@efsa.europa.eu) by the deadline given for the respective active substance. We regret that comments received by EFSA after the respective submission deadline cannot be taken into account. EFSA reserves the right to reject comments not relating to the risk assessment of the active substance.

Consultation is ongoing for the following active substances:
Active substance Existing or new active substance Rapporteur Member State Document type Publication date Deadline for submission of comments
Hymexazol
Existing (3rd stage)
FI
Draft Assessment Report
17/07/2009
07/12/2009
Guazatine
Existing (3rd stage)
UK
Draft Assessment Report
17/07/2009
27/12/2009
Spiroxamine
Annex I Renewal
DE
Assessment Report
21/10/2009
30/11/2009
Hymexazol (additional report)
Re-submission
FI
Additional Report
28/10/2009
07/12/2009
Tau-fluvalinate (additional report)
Re-submission
DK
Additional Report
29/10/2009
08/12/2009
Dichlobenil
Existing (3rd stage)
UK
Draft Assessment Report
03/11/2009
13/12/2009
Dichlobenil (additional report)
Re-submission
UK
Additional Report
03/11/2009
13/12/2009
Dicloran (additional report)
Re-submission
ES
Additional Report
06/11/2009
16/12/2009
Hexythiazox (additional report)
Re-submission
FI
Additional Report
06/11/2009
16/12/2009
8-hydroxyquinoline
Re-submission
ES
Additional Report
13/11/2009
23/12/2009
Guazatine - additional report
Re-submission
UK
Additional Report
17/11/2009
27/12/2009